Be Careful What You Wish For? FDA’s Biosimilars Naming Guidance Proposes New Identifiers For All Biologic Products Read more
UK Health Secretary Announces Mandatory “Sunshine Rule” After Investigation Into Industry Relationships With NHS Employees Read more
Purdue Pharma Settles With New York AG Over Oxycontin Promotion; Agrees To Long List of Requirements To Ensure “Responsible and Transparent Marketing” Read more
Amgen Pays $71 Million to States For Off-Label Allegations In Violation of Consumer Protection Laws Read more
CMS Provides an “Update on Open Payments Reporting” at CBI Transparency and Aggregate Spend Conference Read more